Cortexyme shares owned by Vanguard Group
Historical chart of Vanguard Group investment in Cortexyme
Tip: Access up to 7 years of quarterly data
All positions including Cortexyme held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cortexyme by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.0M | 972k | 1.05 |
| 2023-09-30 | $1.1M | 950k | 1.12 |
| 2023-06-30 | $1.3M | 893k | 1.51 |
| 2023-03-31 | $1.4M | 893k | 1.56 |
| 2022-12-31 | $544k | 853k | 0.64 |
| 2022-06-30 | $1.7M | 788k | 2.22 |
| 2022-03-31 | $7.0M | 1.1M | 6.19 |
| 2021-09-30 | $93M | 1.0M | 91.66 |
| 2021-06-30 | $49M | 916k | 53.00 |
| 2021-03-31 | $31M | 857k | 36.02 |
| 2020-12-31 | $20M | 718k | 27.77 |
| 2020-09-30 | $35M | 698k | 50.00 |
| 2020-06-30 | $28M | 600k | 46.30 |
| 2020-03-31 | $21M | 449k | 45.61 |
| 2019-12-31 | $23M | 412k | 56.14 |
| 2019-09-30 | $5.8M | 233k | 24.91 |